Skip to main content

Featured

Blast at Islamabad Mosque Leaves Dozens Dead

                    Blood stains at the site of a deadly explosion at a Shi'ite Muslim mosque in Islamabad, Pakistan A suicide bomber detonated explosives inside a crowded Shi’ite mosque in Islamabad, killing 31 people and injuring many others during Friday prayers. The attack struck the Tarlai neighborhood, where worshippers had gathered in large numbers, turning a moment of devotion into chaos and devastation. Witnesses described a powerful blast that shattered windows, collapsed parts of the structure, and left victims trapped beneath debris. Emergency teams and local residents worked together to rush the wounded to nearby hospitals, where several remain in critical condition. Authorities have heightened security across the capital as investigators work to determine how the attacker breached the area and whether others were involved. The bombing marks one of the deadliest assaults in the city in years and has intensified ...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment